Daniel Loeb acquired 11.3 Million PDL Biopharma shares worth $27.9 Million. That's 0.39% of their equity portfolio (26th largest holding). The investor owns Inf% of the outstanding PDL Biopharma stock. Daniel Loeb started to build up the position in PDL Biopharma in Q2 2006 and continued to invest until Q2 2007. Since then they sold 100 Thousand shares. The investor's estimated purchase price is $229 Million, resulting in a loss of 88%.